CEL-SCI Corporation

CVM

$1.60

-0.62%

2026-09-04 09:49:47 EDT-$0.01

Healthcare

Biotechnology

AMEX

Active Trading

CEL-SCI Corporation (CVM) focuses on the research and development of immune-based therapies to combat cancer and various infectious diseases. Its flagship immunotherapy ...

Insider Transactions of CVM

Acquisitions (A)

Since Jun 30, 2026

Disposals (D)

Since Jun 30, 2026

Monthly shares of acquisitions/disposals with close price trend (shared daily price source)

Insider Trading Snapshot

Date	Executive	Title	Security	Side	Shares	Price
Aug 25, 2026	KERSTEN GEERT R	director, officer: Chief Executive Officer	Common Stock	A	100,000	$1.38
Aug 14, 2026	Watson Robert Eugene	director	Options	A	110,000	$1.49
Aug 14, 2026	BAILLAVOINE BRUNO JEAN-MARIE	director	Options	A	110,000	$1.49
Aug 14, 2026	CIPRIANO JOHN	officer: Senior Vice President	Options	A	80,000	$1.49
Aug 14, 2026	TALOR EYAL	officer: Chief Scientific Officer	Options	A	250,000	$1.49

Insider Trading Snapshot

Acquisitions (A)

Disposals (D)

Total Shares Bought

1,186,624

Total Shares Sold

Monthly Insider Activity

Monthly shares of acquisitions/disposals with close price trend (shared daily price source)

Transactions by Title - Shares

X-axis: shares, sorted by total shares desc

Transactions by Title - Counts

X-axis: counts, sorted by A+D counts desc

Key People: Buy/Sell Activity and Price

KERSTEN GEERT R

director, officer: Chief Executive Officer • 3 txns

TALOR EYAL

officer: Chief Scientific Officer • 2 txns

PRICHEP PATRICIA B

officer: Chief Financial Officer • 2 txns

Watson Robert Eugene

director • 1 txns

Transactions Table

Date	Executive	Title	Security	Side	Shares	Price	Value
Aug 25, 2026	KERSTEN GEERT R	director, officer: Chief Executive Officer	Common Stock	A	100,000	$1.38	$138,000.00
Aug 14, 2026	Watson Robert Eugene	director	Options	A	110,000	$1.49	$163,900.00
Aug 14, 2026	BAILLAVOINE BRUNO JEAN-MARIE	director	Options	A	110,000	$1.49	$163,900.00
Aug 14, 2026	CIPRIANO JOHN	officer: Senior Vice President	Options	A	80,000	$1.49	$119,200.00
Aug 14, 2026	TALOR EYAL	officer: Chief Scientific Officer	Options	A	250,000	$1.49	$372,500.00
Aug 14, 2026	PRICHEP PATRICIA B	officer: Chief Financial Officer	Options	A	225,000	$1.49	$335,250.00
Aug 14, 2026	KERSTEN GEERT R	director, officer: Chief Executive Officer	Options	A	300,000	$1.49	$447,000.00
Jun 30, 2026	TALOR EYAL	officer: Chief Scientific Officer	Common Stock	A	2,307	$1.04	$2,399.28
Jun 30, 2026	PRICHEP PATRICIA B	officer: Chief Financial Officer	Common Stock	A	4,125	$1.04	$4,290.00
Jun 30, 2026	KERSTEN GEERT R	director, officer: Chief Executive Officer	Common Stock	A	5,192	$1.04	$5,399.68

Supply Chain of CVM

RELATIONS

Upstream

Ergomed Clinical Research (Ergomed Group)LSE:ERGOICON plc (formerly Aptiv Solutions)NASDAQ:ICLRBioRealty, Inc.Diagnostics Partner (Unnamed)Sanofi (historical supplier of Leukine / sargramostim)NASDAQ:SNY

Downstream

Amarox (Saudi Amarox)Teva Pharmaceutical Industries Ltd.NYSE:TEVADallah Healthcare Company (Dallah Pharma)TADAWUL:4004Orient EuroPharma Co., Ltd.

Proxies

Intensity Therapeutics, Inc.NASDAQ:INTSOSE Immunotherapeutics SAENXTPA:OSESensei Biotherapeutics, Inc.NASDAQ:SNSE

About UsPrivacy PolicyTerms of ServiceDisclaimerStock DirectoryETFsIndices13F HoldingsAnalyst TargetsFree ToolsTechnology MapJoin our Slack

Plutux is not an investment adviser. Market data and AI-generated analysis are for information and education only, not investment advice. Disclaimer